361 related articles for article (PubMed ID: 22043293)
1. The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors.
Schmitt KC; Reith ME
PLoS One; 2011; 6(10):e25790. PubMed ID: 22043293
[TBL] [Abstract][Full Text] [Related]
2. Interaction of cocaine-, benztropine-, and GBR12909-like compounds with wild-type and mutant human dopamine transporters: molecular features that differentially determine antagonist-binding properties.
Schmitt KC; Zhen J; Kharkar P; Mishra M; Chen N; Dutta AK; Reith ME
J Neurochem; 2008 Nov; 107(4):928-40. PubMed ID: 18786172
[TBL] [Abstract][Full Text] [Related]
3. R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse.
Loland CJ; Mereu M; Okunola OM; Cao J; Prisinzano TE; Mazier S; Kopajtic T; Shi L; Katz JL; Tanda G; Newman AH
Biol Psychiatry; 2012 Sep; 72(5):405-13. PubMed ID: 22537794
[TBL] [Abstract][Full Text] [Related]
4. Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine.
Chen N; Zhen J; Reith ME
J Neurochem; 2004 May; 89(4):853-64. PubMed ID: 15140185
[TBL] [Abstract][Full Text] [Related]
5. Atypical dopamine transporter inhibitors R-modafinil and JHW 007 differentially affect D2 autoreceptor neurotransmission and the firing rate of midbrain dopamine neurons.
Avelar AJ; Cao J; Newman AH; Beckstead MJ
Neuropharmacology; 2017 Sep; 123():410-419. PubMed ID: 28625719
[TBL] [Abstract][Full Text] [Related]
6. Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter.
Reith ME; Blough BE; Hong WC; Jones KT; Schmitt KC; Baumann MH; Partilla JS; Rothman RB; Katz JL
Drug Alcohol Depend; 2015 Feb; 147():1-19. PubMed ID: 25548026
[TBL] [Abstract][Full Text] [Related]
7. The Isomeric Preference of an Atypical Dopamine Transporter Inhibitor Contributes to Its Selection of the Transporter Conformation.
Abramyan AM; Stolzenberg S; Li Z; Loland CJ; Noé F; Shi L
ACS Chem Neurosci; 2017 Aug; 8(8):1735-1746. PubMed ID: 28441487
[TBL] [Abstract][Full Text] [Related]
8. The unique psychostimulant profile of (±)-modafinil: investigation of behavioral and neurochemical effects in mice.
Mereu M; Chun LE; Prisinzano TE; Newman AH; Katz JL; Tanda G
Eur J Neurosci; 2017 Jan; 45(1):167-174. PubMed ID: 27545285
[TBL] [Abstract][Full Text] [Related]
9. An FSCV Study on the Effects of Targeted Typical and Atypical DAT Inhibition on Dopamine Dynamics in the Nucleus Accumbens Shell of Male and Female Mice.
Hersey M; Chen AY; Bartole MK; Anand J; Newman AH; Tanda G
ACS Chem Neurosci; 2023 Aug; 14(15):2802-2810. PubMed ID: 37466616
[TBL] [Abstract][Full Text] [Related]
10. Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents.
Paterson NE; Fedolak A; Olivier B; Hanania T; Ghavami A; Caldarone B
Pharmacol Biochem Behav; 2010 Jun; 95(4):449-56. PubMed ID: 20346966
[TBL] [Abstract][Full Text] [Related]
11. Relations between stimulation of mesolimbic dopamine and place conditioning in rats produced by cocaine or drugs that are tolerant to dopamine transporter conformational change.
Tanda G; Li SM; Mereu M; Thomas AM; Ebbs AL; Chun LE; Tronci V; Green JL; Zou MF; Kopajtic TA; Newman AH; Katz JL
Psychopharmacology (Berl); 2013 Sep; 229(2):307-21. PubMed ID: 23612854
[TBL] [Abstract][Full Text] [Related]
12. Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors.
Loland CJ; Desai RI; Zou MF; Cao J; Grundt P; Gerstbrein K; Sitte HH; Newman AH; Katz JL; Gether U
Mol Pharmacol; 2008 Mar; 73(3):813-23. PubMed ID: 17978168
[TBL] [Abstract][Full Text] [Related]
13. The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter.
Reith ME; Berfield JL; Wang LC; Ferrer JV; Javitch JA
J Biol Chem; 2001 Aug; 276(31):29012-8. PubMed ID: 11395483
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics of conformation-specific dopamine transporter-inhibitor complexes.
Jean B; Surratt CK; Madura JD
J Mol Graph Model; 2017 Sep; 76():143-151. PubMed ID: 28734204
[TBL] [Abstract][Full Text] [Related]
15. Heterocyclic Analogues of Modafinil as Novel, Atypical Dopamine Transporter Inhibitors.
Kalaba P; Aher NY; Ilić M; Dragačević V; Wieder M; Miklosi AG; Zehl M; Wackerlig J; Roller A; Beryozkina T; Radoman B; Saroja SR; Lindner W; Gonzalez EP; Bakulev V; Leban JJ; Sitte HH; Urban E; Langer T; Lubec G
J Med Chem; 2017 Nov; 60(22):9330-9348. PubMed ID: 29091428
[TBL] [Abstract][Full Text] [Related]
16. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
[TBL] [Abstract][Full Text] [Related]
17. Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substrates.
Schmitt KC; Rothman RB; Reith ME
J Pharmacol Exp Ther; 2013 Jul; 346(1):2-10. PubMed ID: 23568856
[TBL] [Abstract][Full Text] [Related]
18. Targeting of dopamine transporter to filopodia requires an outward-facing conformation of the transporter.
Ma S; Cheng MH; Guthrie DA; Newman AH; Bahar I; Sorkin A
Sci Rep; 2017 Jul; 7(1):5399. PubMed ID: 28710426
[TBL] [Abstract][Full Text] [Related]
19. Novel C-1 substituted cocaine analogs unlike cocaine or benztropine.
Reith ME; Ali S; Hashim A; Sheikh IS; Theddu N; Gaddiraju NV; Mehrotra S; Schmitt KC; Murray TF; Sershen H; Unterwald EM; Davis FA
J Pharmacol Exp Ther; 2012 Nov; 343(2):413-25. PubMed ID: 22895898
[TBL] [Abstract][Full Text] [Related]
20. Effects of ( R)-Modafinil and Modafinil Analogues on Dopamine Dynamics Assessed by Voltammetry and Microdialysis in the Mouse Nucleus Accumbens Shell.
Keighron JD; Quarterman JC; Cao J; DeMarco EM; Coggiano MA; Gleaves A; Slack RD; Zanettini C; Newman AH; Tanda G
ACS Chem Neurosci; 2019 Apr; 10(4):2012-2021. PubMed ID: 30645944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
